Levetiracetam-loaded biodegradable polymer implants in the tetanus toxin model of temporal lobe epilepsy in rats

Grants

Funding Acknowledgements

The authors gratefully acknowledge the donation of Levetiracetam from UCB Pharma, and the sponsorship of the Victorian Government through its Science Technology and Innovation Initiative administered by the Department of Industry, Innovation and Regional Development. The Bionic Ear Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program and the Helen Macpherson Smith Trust. The authors also gratefully acknowledge Dean Freestone and Alan Lai for their assistance in programming the software for review of the EEG data.The sources of support include: (i) the Victorian Government's Science Technology and Innovation Initiative administered by the Department of Industry, Innovation and Regional Development; (ii) the Victorian Government through its Operational Infrastructure Support Program and the Helen Macpherson Smith Trust, to the Bionic Ear Institute.